The Role of Hydrogen Bond Donors and Intramolecular Hydrogen Bonding in Modulating Blood–Brain Barrier Permeability: Implications for CNS Drug Design
Molecules · 2026
DOI: 10.3390/molecules31132366 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecules, 2026. Verfasst von Manuel Novás und 4 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Química Orgánica, Facultad de Farmacia, Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain. Hauptthemen laut MEDLINE: Blood-Brain Barrier, Drug Design, Central Nervous System Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Xunta de Galicia, Xunta da Galicia Grant, Fundación Ramón Areces.
Abstract (Originalsprache)
The blood–brain barrier (BBB) represents a major challenge in central nervous system (CNS) drug development due to its selective permeability. Multiple molecular properties such as lipophilicity, molecular size, and hydrogen-bonding potential critically influence a compound’s ability to cross the BBB. In particular, the presence of hydrogen bond donors (HBDs) and the ability to form intramolecular hydrogen bonds (IMHBs) play a crucial role in modulating brain penetration. This review discusses the mechanistic impact of HBDs and IMHBs on BBB permeability, highlighting key physicochemical parameters and case studies that demonstrate the utility of IMHBs in CNS drug design. Strategies to mask polar functionalities through IMHB formation are emphasized as promising tools to optimize brain delivery without compromising pharmacological activities. The literature reviewed in this work was collected through comprehensive searches of scientific databases, including SciFinder, PubMed, Web of Science, and Scopus, complemented by manual search of reference lists from relevant publications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Departamento de Química Orgánica, Facultad de Farmacia, Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain.
- Biofarma Research Group, Centro de Investigación en Medicina Molecular y Enfermedades Crónicas (CiMUS), Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain.
ORCID-Profile: Manuel Novás, Maria João Matos
Förderung
- Xunta de Galicia
- Xunta da Galicia Grant
- Fundación Ramón Areces
Zitieren
APA
Novás, M., Blanco López, N., Santana, L., Uriarte, E., & Matos, M. J. (2026). The Role of Hydrogen Bond Donors and Intramolecular Hydrogen Bonding in Modulating Blood–Brain Barrier Permeability: Implications for CNS Drug Design. Molecules. https://doi.org/10.3390/molecules31132366
Vancouver
Novás M, Blanco López N, Santana L, Uriarte E, Matos MJ. The Role of Hydrogen Bond Donors and Intramolecular Hydrogen Bonding in Modulating Blood–Brain Barrier Permeability: Implications for CNS Drug Design. Molecules. 2026. doi:10.3390/molecules31132366
BibTeX
@article{Novs2026,
author = {Novás, Manuel and Blanco López, Nuria and Santana, Lourdes and Uriarte, Eugenio and Matos, Maria João},
title = {The Role of Hydrogen Bond Donors and Intramolecular Hydrogen Bonding in Modulating Blood–Brain Barrier Permeability: Implications for CNS Drug Design},
journal = {Molecules},
year = {2026},
doi = {10.3390/molecules31132366}
}
EUVIMED